Meeting
2022 ASCO Annual Meeting
Effect of adjuvant chemotherapy in patients with stage III colon cancer based on the Multi-Institutional Registry of Large Bowel Cancer in Japan.
Authors
Yasuhide Yamada
National Center for Global Health and Medicine, Tokyo, Japan
Yasuhide Yamada , Hirotoshi Kobayashi , Kengo Nagashima , Kenichi Sugihara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer - Neo-Adjuvant/Adjuvant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3610)
DOI
10.1200/JCO.2022.40.16_suppl.3610
Abstract #
3610
Poster Bd #
404
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.
First Author: Olga Martinez Saez
Poster
2016 Gastrointestinal Cancers Symposium
“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
First Author: Jy Ming Chiang
Poster
2024 ASCO Annual Meeting
Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.
First Author: Alberto Puccini
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The efficacy of adjuvant chemotherapy after total mesorectal excision with selective lateral pelvic node dissection for lower rectal cancer.
First Author: Shin Kameishi